Insulin Nation – A Basal Insulin Price War?

People who pay for Lantus might be puzzled if they hear that the company that makes the popular insulin is in trouble. In 2013, sales of Lantus earned Sanofi some $8 billion, and the drug company felt comfortable enough to raise the price of its basal insulin twice in a year.

Read more

Posted in Glucose & Insulin